Hackensack University Medical Center PARTNER is a clinical research site located in Hackensack, New Jersey, United States 07601.
Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.
Hackensack University Medical Center PARTNER has participated in 5 clinical trials with 2 currently active.
Therapeutic areas: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Advanced Solid Tumor.
Sponsors: EMD Serono Research & Development Institute, Inc., Millennium Pharmaceuticals, Inc., Genentech, Inc..
Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Hackensack University Medical Center PARTNER has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hackensack University Medical Center PARTNER has 5 clinical trials on record, with 2 currently active. Their work covers Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Advanced Solid Tumor.
Hackensack University Medical Center PARTNER has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.